1. Home
  2. SSYS vs ACHV Comparison

SSYS vs ACHV Comparison

Compare SSYS & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

N/A

Current Price

$7.04

Market Cap

719.7M

Sector

Technology

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$6.76

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSYS
ACHV
Founded
1989
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
719.7M
726.5M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
SSYS
ACHV
Price
$7.04
$6.76
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$12.00
★ $14.15
AVG Volume (30 Days)
729.9K
★ 1.3M
Earning Date
11-12-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.56
N/A
Revenue Next Year
$3.81
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.67
$2.62
52 Week High
$12.24
$8.64

Technical Indicators

Market Signals
Indicator
SSYS
ACHV
Relative Strength Index (RSI) 41.47 47.06
Support Level N/A $5.96
Resistance Level $8.20 $7.30
Average True Range (ATR) 0.23 0.40
MACD 0.01 0.04
Stochastic Oscillator 61.40 56.07

Price Performance

Historical Comparison
SSYS
ACHV

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd offers polymer-based 3D printing solutions for designers, engineers, manufacturers, dental and medical professionals, and others. Its 3D printing systems utilize the firm's patented extrusion-based FDM, inkjet-based PolyJet, powder-bed-based SAF, photopolymer-based P3, and Neo stereolithography technologies to enable the production of prototypes, tools, and manufactured goods directly from 3D CAD files or other 3D content. The company's solutions portfolio comprises 3D printing systems, consumables, software, paid parts, and professional services, allowing end-users to effectively print 3D models, tools, and parts. Geographically, it generates maximum revenue from the United States, followed by Europe, Middle East and Africa, Asia-Pacific, and other regions.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: